Bajaj Healthcare Q1 FY27 Revenue Up 11.3% YoY to ₹165.6 Cr

Bajaj Healthcare Limited announced its unaudited financial results for Q1 FY27, reporting a 11.3% year-on-year (YoY) increase in revenue from operations to ₹165.6 Crore. Gross profit rose by 16.2% YoY to ₹80.4 Crore, with gross margin expanding to 48.3%. EBITDA grew 16.4% YoY to ₹29.6 Crore, and EBITDA margin improved to 17.8%. Profit after tax (PAT) saw a 15.8% YoY increase to ₹13.7 Crore, with PAT margin at 8.3%. The API division showed strong performance, particularly domestic API sales up 27% YoY. The company also achieved a significant milestone by securing SEC recommendation for Cenobamate Tablets and filed two new CEP applications.